Although conventional treatment’s offer relief for many with Myalgic encephalomyelitis, for others, they can cause unpleasant or unwanted side effects, or simply be ineffective in managing their condition. For these patients with Myalgic encephalomyelitis, medical cannabis may be considered a suitable alternative, or adjunctive treatment, in the UK.
This is because, medical cannabis is multifaceted, and is known to interact with sleep, pain, anxiety, and inflammatory regulation - all of which could help to improve health outcomes for those with myalgic encephalomyelitis. Medical cannabis has its demonstrated potential in improving sleep quality in a number of studies due to its sedative properties, and its positive influence on pain is also well noted in medical journals.
The chemical constituents within medical cannabis (called cannabinoids) can also interact with immune responses. For those with chronic fatigue syndrome, this could prove useful in managing the flu-like symptoms that commonly accompany myalgic encephalomyelitis.
While research in this area is still ongoing, it's important that medical cannabis myalgic encephalomyelitis treatments are carefully monitored for efficacy and safety by qualified healthcare professionals like those that work for Releaf. To find out if you may be eligible for cannabis-based options, fill out our online eligibility form to get more information.